Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Study finds microplastics in most prostate tumors
Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher…
FDA’s Høeg plans to scrutinize SSRIs, RSV shots for babies
WASHINGTON — Tracy Beth Høeg, the top drug regulator at the Food and Drug Administration, indicated in her…
COVID-19 Vaccination During Pregnancy Cut Preeclampsia Risk
COVID-19 infection during pregnancy was associated with a 45% increased risk of preeclampsia, which rose to 78% among…
PhRMA forum shows industry divide between Dr. Oz, Marty Makary
WASHINGTON — Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
Researchers ID Cause of Blood Clots After COVID Vaccines
Scientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after…
Bioengineered E. coli bacteria can now produce rhododendron-derived drugs
Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.…
Study reveals a new facet of how pancreatic cancer cells regulate autophagy
A feature of pancreatic cancer cells’ surroundings determines whether they grow fast or become resistant to chemotherapy, a…
Consumer group presses U.S. to authorize generic GLP-1s
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
CRISPR Unlocks a New Path to Stronger Medicinal Plants
Newswise — Medicinal plants synthesize a wide range of specialized metabolites that form the foundation of many modern…
Crick spin‑out ALTx will target cancer cell immortality
Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…